What is the Global Myeloma Action Network (GMAN)?
In 2013, the International Myeloma Foundation led the development of the Global Myeloma Alliance, which later became the Global Myeloma Action Network (GMAN) in 2014.
GMAN is a group of multiple myeloma leaders' patient organizations around the world whose aim is to support the needs of myeloma patients’ needs.
While each member organization has its own mission and vision, GMAN works to convene members and partners to share best practices, address mutual areas of concern, and elevate awareness of multiple myeloma.
The goals set forth are those that GMAN can aspire to work on collaboratively.
- Raise the profile and enhance the capabilities of patient advocacy groups around the globe through best practice sharing and capacity- building
- Elevate global awareness of multiple myeloma
- Ensure access to new and effective treatment for myeloma patients around the world
- Improve patient outcomes through earlier diagnosis
- Advance innovation in blood cancer through advocacy and policy engagement
- Promote education and information to patients, caregivers, physicians, and policymakers
Learn More About the IMF's Global Advocacy Initiative
In order to achieve GMAN’s goals, members must fulfill their stated roles, agree upon core success factors and be willing to support the execution identified strategies in a collaborative way.
Core success factors
GMAN must establish a number of critical success factors in order to effectively execute its goals.
Maintain at least one IMF staff person dedicated to overseeing the operations of GMAN with additional support from IMF staff as needed.
Cultivate additional funding from a diverse base of external stakeholders supportive of the multiple myeloma patient population. Donation parameters should be developed and agreed upon by members and/or the steering committee.
Members must meet identified criteria and agree to member requirements to enjoy full member benefits.
Synergistic external partnerships
Identify collaborative initiatives, programs, and activities of value with strategic partners to help empower and broaden audience reach, build credibility and/or sustain/develop financial support.
Execute a modest marketing initiative to generate awareness and begin to build the brand of GMAN among key audiences.
On December 15, 2021, representatives of the Global Myeloma Action Network (GMAN) member organizations gathered to hear about upcoming myeloma therapies and other news from the 2021 American Society of Hematology Annual Meeting (ASH 2021).
Global Myeloma Action Network (GMAN) developed the International Myeloma Patient Charter to ensure that no matter where in the world a person lives the following principles apply to people affected by multiple myeloma and those involved in their lives and treatments. We believe that all parties involved in a patient’s journey have a responsibility to meet the expectations expressed in this document.
Susie Novis Durie Educational Grants, created to help member organizations of the IMF’s Global Myeloma Action Network (GMAN) increase education, awareness, and access to treatment.
This year’s annual GMAN Summit was held virtually on August 25–26, 2021, with 50 advocates from 5 continents and 30 countries in attendance.